71% efter en 40 mg dosis, når denne administreres som to tabletter med modificeret udløsning af nicotinsyre/ laropiprant efter en nats faste.
The mean absolute bioavailability of laropiprant is approximately 71% following a 40 mg dose when administered as two modified-release tablets of nicotinic acid/ laropiprant after an overnight fast.